Highlights Innovation1 Biotech Inc.

Equities

IVBT

US39809D2018

Delayed OTC Markets Other stock markets 09:31:07 2024-04-19 am EDT			5-day change	1st Jan Change
0.0008 ^USD	-96.36%		-.--%	-99.07%

Jan. 17	Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	CI
2023	Innovation1 Biotech Inc. announced that it has received $0.15 million in funding	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	Jan. 17	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	23-09-13	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	23-05-30	CI
Innovation1 Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	23-01-17	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	22-12-15	CI
INNOVATION1 BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-12-12	AQ
Innovation1 Biotech Inc. Announces Board Appointments	22-12-12	CI
Ingenius Biotech S.L. acquired All Of The Assets Relating to Mioxal from Innovation1 Biotech Inc. for $0.1 million.	22-11-13	CI
INNOVATION1 BIOTECH INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-09-15	AQ
Innovation1 Biotech Inc. Announces Filing of Patent Application for Novel Combination Therapy Targeting Addiction	22-08-18	CI
Innovation1 Biotech : Appoints Chief Scientific Officer Andrew L. Salzman, M.D. to its Board of Directors - Form 8-K	22-08-15	PU
Innovation1 Biotech Appoints Chief Scientific Officer Andrew L. Salzman, M.D. to its Board of Directors	22-08-11	AQ
Innovation1 Biotech Inc. Appoints Andrew L. Salzman, M.D., to Its Board of Directors	22-08-11	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2022	22-07-14	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2022	22-04-15	CI
Gridiron BioNutrients, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021	22-01-19	CI
Gridiron BioNutrients, Inc. Reports Earnings Results for the Full Year Ended August 31, 2021	21-12-10	CI
Gridiron Bionutrients, Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2021	21-07-13	CI
Gridiron Bionutrients, Inc. Reports Earnings Results for the Second Quarter Ended February 28, 2021	21-04-14	CI
Gridiron Bionutrients, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2020	21-01-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Innovation1 Biotech Inc.

Equities

IVBT

US39809D2018

Highlights

Filters